APcK110
APcK110 is a potent Kit inhibitor that can be used for the research of acute myeloid leukemia (AML). APcK110 induces AML cell apoptosis.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 1001083-74-4
- Formule: C20H16FN3O2
- Masse moléculaire:349.36
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
APcK110 (0-500 nM; 0-72 h) inhibits AML cell viability and proliferation. APcK110 preferentially inhibits KIT mutated BaF3 cell lines[1].
APcK110 (0-500 nM; 30 min) inhibits the phosphorylation of Kit, Stat3, Stat5, and Akt[1].
APcK110 (500 nM; overnight) induces caspase-dependent apoptosis in OCI/AML3 cells[1].
APcK110 (50-500 nM; 7 days) inhibits AML blast colony-forming cell proliferation[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:OCI/AML3, HMC1.2, BaF3 and mutant KIT-expressing BaF3 cells
-
Concentration:0-500 nM
-
Incubation Time:0, 24, 48 and 72 h
-
Result:Inhibited proliferation in a dose-dependent manner.
-
Cell Line:OCI/AML3 and HMC1.2
-
Concentration:0, 50, 100, 250 and 500 nM
-
Incubation Time:30 min
-
Result:Showed a dose-dependent inhibition of the phosphorylation of Kit, Stat3, Stat5, and Akt, a downstream effector of phosphatidylinositol 3-kinase.
-
Cell Line:OCI/AML3 cells
-
Concentration:500 nM
-
Incubation Time:Overnight
-
Result:Induced apoptosis by activation of the caspase pathway.
-
Cell Line:OCI/AML3 cells
-
Concentration:500 nM
-
Incubation Time:2 h
-
Result:Showed a shift of cells into sub-G0 following a 2 h incubation.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Eight-weeks-old female NODSCID mice, OCI/AML3 xenograft mouse model[2]
-
Dosage:500 nM
-
Administration:Intraperitoneal injection, every other day for 60 days
-
Result:Survival of compound-treated mice was significantly longer compared with mice injected with PBS.
Chemical Information
-
CAS No. 1001083-74-4
-
Masse moléculaire 349.36
-
Formule C20H16FN3O2
-
SMILES
FC1=CC=C(C2=NNC3=NC(C4=CC(OC)=CC(OC)=C4)=CC=C23)C=C1
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Faderl S, et al. Kit inhibitor APcK110 induces apoptosis and inhibits proliferation of acute myeloid leukemia cells. Cancer Res. 2009 May 1;69(9):3910-7. [Content Brief]
[2]. Faderl S, et al. Kit inhibitor APcK110 extends survival in an AML xenograft mouse model. Invest New Drugs. 2011 Oct;29(5):1094-7. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
APcK110 Related Classifications
HY-110071 Related Classifications
Powered by Bioz